BlockNews
  • Crypto
  • Finance
  • Politics
  • Memecoins
  • NFT
  • Technology
  • Opinion
No Result
View All Result
FOLLOW
BlockNews
  • Crypto
  • Finance
  • Politics
  • Memecoins
  • NFT
  • Technology
  • Opinion
No Result
View All Result
BlockNews

Trump’s Pharma Tariffs Could Trigger Drug Shortages Nationwide​, Warn Healthcare Experts

by Sham
April 14, 2025
in Finance, Opinion, Politics
A A
Trump’s Pharma Tariffs Could Trigger Drug Shortages Nationwide​, Warn Healthcare Experts
2
SHARES
Share on TwitterShare on Reddit
  • Trump’s proposed drug tariffs could hit generics the hardest and worsen ongoing medication shortages.
  • Pharma CEOs warn the tariffs may force them to cut R&D instead of raising prices due to regulatory caps.
  • Health experts and officials say the policy shift could damage global supply chains and harm patient access.

The pharmaceutical world is bracing itself for a tough road ahead after President Donald Trump hinted at what he called a “major tariff” on imported prescription drugs. While details are still murky, Trump said the U.S. can’t even make enough antibiotics anymore, and that’s something he’s aiming to fix—with tariffs, apparently.

🚨 DONALD TRUMP: Pharmaceutical tariffs coming in the not-too-distant future 👀

— BlockNews (@blocknewsdotcom) April 14, 2025

Industry On Edge, Patients at Risk

Drug companies are worried. A lot. Tariffs on pharmaceuticals would throw global supply chains into chaos, and most generic meds—90% of prescriptions in the U.S.—depend on ingredients from places like China and India. Generic drugmakers don’t have the same profit margins as big-name brands, so they can’t just jack up prices to stay afloat. Instead, some might bail completely, which means shortages. Bad ones.

“We’re less concerned about the prices rising,” said Tom Kraus from the American Society of Health-System Pharmacists. “What really scares us is companies just dropping out entirely.” He says sterile injectables and antibiotics, already in short supply, could get even harder to find.

Tariffs Could Range From 50% to 200%

Trump’s plan, which he vaguely referenced again this week, wouldn’t be part of the broader 90-day pause on most country-specific tariffs. Treasury Secretary Scott Bessent confirmed that pharmaceutical tariffs, like those on China (now at 145%), are exempt from that freeze. Trump mentioned that these new drug import duties could land anywhere from 50% to a whopping 200%.

The administration might frame the rollout differently, potentially linking it to national security investigations—basically copying the playbook used for steel and aluminum in previous years.

Brand Names Might Survive—Generics, Not So Much

Brand-name drug companies have started moving production back to the U.S. already, and with their higher profit margins, they might be able to handle the tariffs. Generics? Not so much. Once the price of making them outweighs the revenue, companies just stop producing—and boom, another shortage.

Marta Wosińska, a senior fellow at Brookings, put it bluntly: “We use generics and spend on brands.” That means patients will likely feel the pain on both ends—whether it’s access or affordability.

CEOs Say: Don’t Do It

Leaders from top pharmaceutical firms like AstraZeneca and Eli Lilly are pushing back hard. “Medicines should be exempt,” said AstraZeneca Chair Michel Demaré. Eli Lilly CEO David Ricks warned that his company might slash R&D instead of hiking prices, because penalties exist for raising drug costs too quickly. “We’ll have to eat the cost,” he said. “This is a hard pivot for the U.S., and it’ll be tough to reverse.”

Pharmaceutical World is Bracing Itself for a Tough Road Ahead

FDA Layoffs and Kennedy’s Criticism Add More Fire

If that wasn’t enough uncertainty, the FDA is going through major layoffs. And Health and Human Services Secretary Robert F. Kennedy Jr. is out here calling pharmaceutical drugs the “third-biggest killer of Americans.” In an interview this week, he said the industry has done amazing things—but also, it’s driven by profit, and that’s dangerous.

All in all, with potential tariffs looming, global supply chains rattled, and political rhetoric ramping up, the pharmaceutical sector is staring down what could be one of its most disruptive periods in decades.

Tags: ChinaDonald TrumpIndiatariffTom Kraus
Tweet1ShareShare1

DON'T MISS THESE! HOT OFF THE PRESS

Analysts Predict Major Rally for Polkadot DOT Following This Bullish Technical Breakout (Still Early)
Crypto

Analysts Predict Major Rally for Polkadot DOT Following This Bullish Technical Breakout (Still Early)

May 12, 2025
Pi Network Soars to $1.30 Ahead of MAJOR May 14 Launch: Here is What You Need to Know
Crypto

Pi Network Soars to $1.30 Ahead of MAJOR May 14 Launch: Here is What You Need to Know

May 12, 2025
Shiba Inu SHIB Bullish Momentum Builds as Whales Increase Holdings: Here is What Big Money Doesn’t Want You to Know
Crypto

Shiba Inu SHIB Bullish Momentum Builds as Whales Increase Holdings: Here is What Big Money Doesn’t Want You to Know

May 12, 2025
Ethereum’s 40% Weekly Surge Puts 60% of Holders in Profit: Here is Why You’re Still Early
Crypto

Ethereum’s 40% Weekly Surge Puts 60% of Holders in Profit: Here is Why You’re Still Early

May 12, 2025
Analysts Predict PEPE Coin Will Reach 1 Cent by THIS Date (ACT NOW)
Crypto

Analysts Predict PEPE Coin Will Reach 1 Cent by THIS Date (ACT NOW)

May 12, 2025
Ethereum’s Upcoming Fusaka Upgrade Will Greatly Reduce Validator Costs: Is This Bullish for ETH Investors?
Crypto

Ethereum’s Upcoming Fusaka Upgrade Will Greatly Reduce Validator Costs: Is This Bullish for ETH Investors?

May 12, 2025
Load More

Related News

Analysts Predict Major Rally for Polkadot DOT Following This Bullish Technical Breakout (Still Early)

Analysts Predict Major Rally for Polkadot DOT Following This Bullish Technical Breakout (Still Early)

May 12, 2025
Pi Network Soars to $1.30 Ahead of MAJOR May 14 Launch: Here is What You Need to Know

Pi Network Soars to $1.30 Ahead of MAJOR May 14 Launch: Here is What You Need to Know

May 12, 2025
Shiba Inu SHIB Bullish Momentum Builds as Whales Increase Holdings: Here is What Big Money Doesn’t Want You to Know

Shiba Inu SHIB Bullish Momentum Builds as Whales Increase Holdings: Here is What Big Money Doesn’t Want You to Know

May 12, 2025
Ethereum’s 40% Weekly Surge Puts 60% of Holders in Profit: Here is Why You’re Still Early

Ethereum’s 40% Weekly Surge Puts 60% of Holders in Profit: Here is Why You’re Still Early

May 12, 2025
Analysts Predict PEPE Coin Will Reach 1 Cent by THIS Date (ACT NOW)

Analysts Predict PEPE Coin Will Reach 1 Cent by THIS Date (ACT NOW)

May 12, 2025
Discord Twitter Youtube TikTok Instagram

BLOCKNEWS.COM

BlockNews

BlockNews.com is your premier source for real-time cryptocurrency, blockchain, and financial market news.

Our mission is to deliver accurate, timely, and insightful information to help both seasoned investors and newcomers navigate the evolving digital economy.

With in-depth analysis, exclusive insights, and up-to-date news, BlockNews.com keeps you informed on the latest trends in crypto, DeFi, NFTs, tech, and beyond.

Stay ahead of the herd with BlockNews.com

RESOURCES

  • About
  • Newsletter
  • Advertise
  • Terms and Conditions
  • Privacy Policy

POPULAR TOPICS

$ADA $XRP AI Avalanche Binance Bitcoin Bitcoin ETF blackrock Blockchain BTC Business Cardano China Coinbase crypto cryptocurrency Crypto Exchange Crypto Regulation DeFi Dogecoin Donald Trump Elon Musk ETF eth ethereum Federal Reserve FTX grayscale Memecoin Meme Coin metaverse Microstrategy NFT NFTs PEPE ripple sec Shiba Inu Solana Stablecoin Technology twitter US Web3 xrp

GET QUICKER UPDATES ON X

© 2022-2025 BlockNews.com - Crypto and NFT news website by Aiur Labs.

No Result
View All Result
  • Home
  • Crypto
  • Memecoins
  • Technology
  • Politics
  • Finance
  • NFT
  • DeFi
  • Opinion

© 2022-2025 BlockNews.com - Crypto and NFT news website by Aiur Labs.